Table 3.
Plasma levels of FDP, D-dimer, and soluble fibrin between patients with atherosclerotic or lacuna ACI and other ACI and between ACI patients treated with and without antithrombotic agents.
| Soluble Fibrin (μg/mL) | FDP (μg/mL) |
D-Dimer A (μg/mL) |
D-Dimer B (μg/mL) |
D-Dimer C (μg/mL) |
|
|---|---|---|---|---|---|
| Atherosclerotic or lacuna ACI | 4.7 NS (2.4–11.4) |
1.3 ** (0.8–2.5) |
1.1 * (0.5–2.0) |
1.0 ** (0.6–1.9) |
1.0 ** (0.6–1.8) |
| Other ACI | 5.9 NS (2.3–11.4) |
2.1 ** (1.1–3.5) |
1.6 * (0.6–3.0) |
1.5 ** (0.7–2.9) |
1.4 ** (0.7–2.8) |
| ACI without antithrombotic agents | 5.6 NS (2.2–10.7) |
1.7 NS (1.0–3.1) |
1.2 NS (0.5–2.5) |
1.2 NS (0.6–2.5) |
1.1 NS (0.7–2.4) |
| ACI with antithrombotic agents | 6.5 NS (2.6–12.7) |
1.4 NS (0.9–2.6) |
1.2 NS (0.5–2.3) |
1.1 NS (0.6–2.5) |
1.2 NS (0.7–2.4) |
ACI, acute cerebral infarction; FDP, fibrinogen and fibrin degradation product; D-dimer (A), D-dimer (A), LIASAUTO D-dimer Neo; D-dimer (B), LPIA ACE-D-dimer; D-dimer (C), LPIA genesis D-dimer; NS, not significant; **, p < 0.01; *, p < 0.05.